                         SEQUENCE LISTING

<110>  United States Of America, As Represented By The Secretary, 
       Department Of Health And Human Services
 
<120>  DETECTION OF LIVE ATTENUATED INFLUENZA VACCINE VIRUSES

<130>  1029174

<150>  US 62/267,085
<151>  2015-12-14

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic LAIV-A forward primer

<400>  1
gaagcaaaga ttgaacaaga gaagc                                             25


<210>  2
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic LAIV-A reverse primer

<400>  2
cacaaatact tctcgctagt gtttcg                                            26


<210>  3
<211>  31
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Syntehtic LAIV-A probe

<400>  3
cactgacatt gaacacaatg actaaagatg c                                      31


<210>  4
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic LAIV-B forward primer

<400>  4
atgagttggg gctggcta                                                     18


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Syntehtic LAIV-B reverse primer

<400>  5
ccacagcttc cataagaagt                                                   20


<210>  6
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic LAIV-B Probe

<400>  6
ttcttggact tcccttcag                                                    19


